Enforcement record
Business Suspension Order disclosure naming 一般財団法人化学及血清療法研究所
This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.
Action type
Business Suspension Order
Law
医薬品医療機器法
Authority
Ministry of Health, Labour and Welfare
Action date
18 January 2016
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-OTHER-HUA-XUE-JI--202608041428
- Generated at
- 4 August 2026 at 23:28
- Record URL
- https://regbase.jp/en/enforcement/other-hua-xue-ji-xie-qing-liao-fa-yan-jiu-suo-20160118
1. Review Summary
| Disclosure name | 一般財団法人化学及血清療法研究所 | Corporate Number | Not stated in the disclosure |
|---|---|---|---|
| Enforcement record | 1 record | Other confirmed records for this company | Outside this report's scope |
| Action date | 18 January 2016 | Authority | Ministry of Health, Labour and Welfare |
| Law | 医薬品医療機器法 | Action type | Business Suspension Order |
| Source status | Preserved public-source archive recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Published Information
| Published name | 一般財団法人化学及血清療法研究所 |
|---|
3. Enforcement Record
| Target name in disclosure | 一般財団法人化学及血清療法研究所 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | 医薬品医療機器法 / Business Suspension Order |
| Action / announcement date | Action: 18 January 2016 / Announcement: 27 March 2026 |
| English summary | The Ministry of Health, Labour and Welfare has issued an administrative suspension order to the General Incorporated Foundation, Chemical and Serum Therapy Institute, based on Article 75, Paragraph 1 of the Pharmaceuticals and Medical Devices Act, for a period of 110 days from January 18, 2016 (Monday) to May 6, 2016 (Friday). |
| Original Japanese text | 厚生労働省では、本日付けで、一般財団法人化学及血清療法研究所に対し医薬品医療機器法第75条第１項の規定に基づき、別紙のとおり平成28年１月18日(月)から同年５月６日(金)までの110日間の業務停止命令(行政処分)を行いましたので、お知らせします。 |
| Official source | https://www.mhlw.go.jp/stf/houdou/0000108663.html |
| Source archive | https://kiroku.today/a/aa596a4b22hemg04 |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 08:34 / Evidence checked: 25 April 2026 at 08:34 / Archive captured: 12 July 2026 at 15:24 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Confirmed Records for This Company
This report covers the single government disclosure shown on this page.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.
Free report
Save the disclosure record naming 一般財団法人化学及血清療法研究所
Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Preserved evidence by Kiroku
Review the preserved source for 一般財団法人化学及血清療法研究所
Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- 一般財団法人化学及血清療法研究所Japanese onlyOriginal: 一般財団法人化学及血清療法研究所
- Governing law
- 医薬品医療機器法医薬品医療機器法
- Action type
- Business Suspension Order業務停止命令
- Action date
- 18 January 2016
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品医療機器
Violation
The Ministry of Health, Labour and Welfare has issued an administrative suspension order to the General Incorporated Foundation, Chemical and Serum Therapy Institute, based on Article 75, Paragraph 1 of the Pharmaceuticals and Medical Devices Act, for a period of 110 days from January 18, 2016 (Monday) to May 6, 2016 (Friday).
Show original Japanese text
厚生労働省では、本日付けで、一般財団法人化学及血清療法研究所に対し医薬品医療機器法第75条第１項の規定に基づき、別紙のとおり平成28年１月18日(月)から同年５月６日(金)までの110日間の業務停止命令(行政処分)を行いましたので、お知らせします。
Compliance context
HighA formal order requiring suspension of business activities for the covered scope or period.
Japanese regulatory disclosure under 医薬品医療機器法.
Escalate for legal or third-party risk review before onboarding or continuing a material relationship.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-24T23:34:23.912+00:00
- Evidence checked
- 2026-04-24T23:34:23.912+00:00
- Archive captured
- 2026-07-12T06:24:34.07897+00:00
Show audit JSON
{
"record": {
"id": "26d42f29-3d7e-4ca6-b555-c4d1cfb1f896",
"url": "https://regbase.jp/en/enforcement/other-hua-xue-ji-xie-qing-liao-fa-yan-jiu-suo-20160118",
"company_name_original": "一般財団法人化学及血清療法研究所",
"company_name_registry": null,
"corporate_number": null,
"law": {
"ja": "医薬品医療機器法",
"en": "医薬品医療機器法"
},
"action_type": {
"ja": "業務停止命令",
"en": "Business Suspension Order"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "unresolved",
"confidence": 85,
"method": "nta_strict_name_nationally_unique",
"method_label": "nta_strict_name_nationally_unique",
"notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (一般財団法人化学及血清療法研究所). No Corporate Number was present in the disclosure, so this remains a likely match."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "High",
"actionMeaning": "A formal order requiring suspension of business activities for the covered scope or period.",
"practicalNote": "Escalate for legal or third-party risk review before onboarding or continuing a material relationship.",
"lawContext": "Japanese regulatory disclosure under 医薬品医療機器法."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-hua-xue-ji-xie-qing-liao-fa-yan-jiu-suo-20160118",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000108663.html",
"officialDocumentUrl": null,
"archiveUrl": "https://kiroku.today/a/aa596a4b22hemg04",
"archivedSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000108663.html",
"archiveCapturedAt": "2026-07-12T06:24:34.07897+00:00",
"extractedAt": "2026-04-24T23:34:23.912+00:00",
"translatedAt": "2026-05-01T06:50:08.227+00:00",
"evidenceCheckedAt": "2026-04-24T23:34:23.912+00:00",
"generatedAt": "2026-08-04T14:28:46.816Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.